	Aging with multiple sclerosis and associated prevalence, incidence, comorbidities and healthcare utilization patterns in a population based study. Sci Rep Staun-Ram E, Neter E, Glass-Marmor L, Stein N, Miller A. PMID: 42324325 [PubMed - as supplied by publisher]
	Natalizumab is associated with improved relapse outcomes and lower healthcare utilization versus ocrelizumab in treatment-naÃ¯ve people with multiple sclerosis. J Med Econ Kaplan J, Beenstock D, Belkin M, Crayton H, Eckstein C, Fredericks R, Bian B, Belviso N, Ni D, Rutledge D. PMID: 42323726 [PubMed - indexed for MEDLINE]
	Pregnancy outcomes in patients with multiple sclerosis with or without exposure to disease-modifying treatment: A retrospective cohort study on Iranian population. Mult Scler Relat Disord Paybast S, Asl Fallah E, Sahraian MA, Azimi AR. PMID: 42322960 [PubMed - as supplied by publisher]
	Exploratory analysis of pupillography-based machine learning for assessing autonomic dysfunction in multiple sclerosis. Mult Scler Relat Disord Parmak Yener N, F, Sefero, Karg, K. PMID: 42322958 [PubMed - as supplied by publisher]
	Prognostic value of neurofilament light chain protein and glial fibrillary acidic protein in multiple sclerosis subtypes and disease activity patterns: a systematic review and meta-analysis. Neurol Sci Yang C, Jiang C, Wang Y, Hu Y, Li Y, Zhou P, Wang Y. PMID: 42322442 [PubMed - indexed for MEDLINE]
	Co-development of a protocol for a randomised controlled feasibility trial of CIRCuiTSâ„¢ cognitive remediation therapy for people with multiple sclerosis. Pilot Feasibility Stud Thomas RJ, Cella M, Brex PA, Silber E, Fifield K, Burke P, Summers M, Simblett S, Wykes T. PMID: 42321924 [PubMed - as supplied by publisher]
	Neurofilament light chain and glial fibrillary acidic protein as biomarkers of peripheral nervous system involvement in multiple sclerosis: diagnostic and prognostic evaluation. BMC Neurol Flintere-Flinte A, Krutovs V, Pantelejeva E, Blennow K, Zetterberg H, Zolovs M, Kenina V. PMID: 42321679 [PubMed - as supplied by publisher]
	Adjunctive Dulaglutide in Relapsing-Remitting Multiple Sclerosis: A Randomized Open-Label Proof-of-Concept Trial. Neurol Ther , Rádiková , Kollár B, Kut, Penesová A, Havranová A, Imrich R, Vl, , Krastev G, Tur. PMID: 42321509 [PubMed - as supplied by publisher]
	Epstein-Barr virus and multiple sclerosis: from associations to mechanisms to potential therapies. Lancet Neurol Lünemann JD, Münz C. PMID: 42320500 [PubMed - as supplied by publisher]
	Effects of high-dose vitamin D supplementation in patients with multiple sclerosis: A systematic review of efficacy and safety. Mult Scler Relat Disord Ghamdi KA, Alqarni M, Alamri Z, Wahhas MA, Alkhaldi M, Alsanni A, Alhawaj AF. PMID: 42320168 [PubMed - as supplied by publisher]
	Pearls & Oy-sters: Radiologic Lag in Pediatric-Onset Multiple Sclerosis. Neurology Mirchi A, Vossough A, Liu GT, Narula S. PMID: 42320011 [PubMed - indexed for MEDLINE]
	Epidemiology of multiple sclerosis in a healthcare area of the Basque Country, Northern Spain: A population-based study (2009-2023). Mult Scler J Exp Transl Clin Sánchez-Menoyo JL, Boyero-Durán S, Llarena-González C, Roncero-Colina N, Mendibe-Bilbao M, Vázquez-Picón S, Agirre-Larrakoetxea U, Azkune-Calle I, Valdeolivas-Urbelz E, Rodríguez-Antigüedad A. PMID: 42317494 [PubMed]
	Added diagnostic value of postcontrast susceptibility-weighted imaging with 1.5-Tesla magnetic resonance imaging for central vein sign assessment in multiple sclerosis. Diagn Interv Radiol Atalay B, Yamer M, Do. PMID: 42317115 [PubMed - as supplied by publisher]
	Simultaneous T(2), T(2)*, and R(2)' Mapping for Multiple Sclerosis Using Nonlinear Model-Based Reconstruction of Undersampled Radial RARE-EPI MRI. Magn Reson Med Velasquez Vides JR, Herrmann CJJ, Gladytz T, Hetherington HP, Mattern H, Wang X, Millward JM, Shalikar S, Tellez Ceja IF, Endemann B, Waiczies S, Kuchling J, Paul F, Rose G, Ku MC, Schmitt F, Niendorf T. PMID: 42316513 [PubMed - as supplied by publisher]
	Mediterranean-DASH intervention for neurodegenerative delay (MIND) diet intervention in persons with multiple sclerosis: A feasibility, randomized controlled trial. Nutr Res Martell SG, Holthaus TA, Verma S, Adamson B, Motl RW, Khan NA. PMID: 42314522 [PubMed - as supplied by publisher]
	Comparable Infection Risk of Ocrelizumab and Rituximab in Multiple Sclerosis in a Nationwide Swedish Cohort Study. Ann Neurol Frisell T, Hedberg S, Piehl F. PMID: 42310849 [PubMed - as supplied by publisher]
	Bruton's tyrosine kinase inhibitors: a new class of multiple sclerosis therapeutics. Lancet Neurol Oh J, Bar-Or A, Montalban X, Sormani MP, Weber MS, Reich DS. PMID: 42309088 [PubMed - indexed for MEDLINE]
	Optic nerve involvement in multiple sclerosis diagnosis - Authors' reply. Lancet Neurol Saidha S, Green AJ, Balcer L, Calabresi PA, authors of the 2024 McDonald criteria for the diagnosis of multiple sclerosis. PMID: 42309078 [PubMed - in process]
	Optic nerve involvement in multiple sclerosis diagnosis. Lancet Neurol Luo W, Wei Z, Huang X, Du Y. PMID: 42309077 [PubMed - in process]
	Technological solutions for multiple sclerosis: a scoping review. Int J Med Inform Lima B, Guimaraes J, Fernandes CS, Ferreira MC. PMID: 42308950 [PubMed - as supplied by publisher]

Articles 1 - 20 / 44275

Page 1 of 2214



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy